U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H18N2O
Molecular Weight 278.3483
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0
Stereo Comments Meso

SHOW SMILES / InChI
Structure of AC-262536

SMILES

O[C@@H]1C[C@@H]2CC[C@H](C1)N2C3=CC=C(C#N)C4=C3C=CC=C4

InChI

InChIKey=ATKWLNSCJYLXPF-FICVDOATSA-N
InChI=1S/C18H18N2O/c19-11-12-5-8-18(17-4-2-1-3-16(12)17)20-13-6-7-14(20)10-15(21)9-13/h1-5,8,13-15,21H,6-7,9-10H2/t13-,14+,15+

HIDE SMILES / InChI

Approval Year

Name Type Language
AC-262536
Common Name English
4-(3-ENDO-HYDROXY-8-AZABICYCLO(3.2.1)OCT-8-YL)NAPHTHALENE-1-CARBONITRILE
Systematic Name English
1-NAPHTHALENECARBONITRILE, 4-((3-ENDO)-3-HYDROXY-8-AZABICYCLO(3.2.1)OCT-8-YL)-
Systematic Name English
AC 262536
Code English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-AC-262536
Created by admin on Sat Dec 16 09:14:54 GMT 2023 , Edited by admin on Sat Dec 16 09:14:54 GMT 2023
Code System Code Type Description
FDA UNII
U8VS41J5O6
Created by admin on Sat Dec 16 09:14:54 GMT 2023 , Edited by admin on Sat Dec 16 09:14:54 GMT 2023
PRIMARY
CAS
870888-46-3
Created by admin on Sat Dec 16 09:14:54 GMT 2023 , Edited by admin on Sat Dec 16 09:14:54 GMT 2023
PRIMARY
EPA CompTox
DTXSID701336168
Created by admin on Sat Dec 16 09:14:54 GMT 2023 , Edited by admin on Sat Dec 16 09:14:54 GMT 2023
PRIMARY
PUBCHEM
44512434
Created by admin on Sat Dec 16 09:14:54 GMT 2023 , Edited by admin on Sat Dec 16 09:14:54 GMT 2023
PRIMARY
WIKIPEDIA
AC-262,536
Created by admin on Sat Dec 16 09:14:54 GMT 2023 , Edited by admin on Sat Dec 16 09:14:54 GMT 2023
PRIMARY AC-262,356 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator. Chemically it possesses endo-exo isomerism, with the endo form being the active form. It acts as a partial agonist for the androgen receptor with a Ki of 5nM, and no significant affinity for any other receptors tested. In animal studies it produced a maximal effect of around 66% of the anabolic action of testosterone, but only around 27% of its potency as an androgen.
DRUG BANK
DB13935
Created by admin on Sat Dec 16 09:14:54 GMT 2023 , Edited by admin on Sat Dec 16 09:14:54 GMT 2023
PRIMARY